NorthWest Biotherapeutics Inc (NWBO)

[austinmediainc]

I'll answer my own question, because ARGOS has to catch up to Cognate, and it is trying to develop similar manufacturing capabilities in-house.

C'mon Flipper that isn't true. They are currently spending less than half of what we are,
- they are currently running a similar 450 patient Phase III study for metastatic renal cell carcinoma(20-25k new cases a year in US) that has been granted SPA by the FDA and received fast track designation
- active at 135 sites in North America, Europe and Isreal
- a similar process to produce for the trial which should have similar costs
- they have also completed a Phase I and II in this study. While we have only done the Phase I
- Ramping up to start 2 additional Phase II studies for early RCC and other solid tumors
- Currently running a Phase IIb trial for HIV(yes that is being funded by the NIH)
- Starting 2 more Phase IIa studies for pediatric and adult eradication
- Broke ground on a manufacturing facility that will serve NA and they will own and control
- AND they have 50 million in C and CE's that will take them through their current Phase III mRCC trial results.
- Only 26 million total shares with 12 million being owned by insiders, more reason they wouldn't want to dilute as much as NWBO Linda to herself..........

Are you really going to try and make me believe that NWBO is way ahead of that? We are running a smaller Phase III for L and have run a small Phase I for Direct trial at 2 sites. I don't mind being wrong but let's call it for what it is.